Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2006
12/21/2006US20060286577 Methods for detection of methylated DNA
12/21/2006US20060286576 Methods and nucleic acids for the analyses of cellular proliferative disorders
12/21/2006US20060286575 MCL-1 quadruplex nucleic acids and uses thereof
12/21/2006US20060286574 Compositions and methods for enhancing drug sensitivity and treating drug resistant infections and diseases
12/21/2006US20060286573 Method for determining nucleotide sequence of nucleic acid molecule by utilizing scanning probe microscope
12/21/2006US20060286572 Method for producing chemically synthesized and in vitro enzymatically synthesized nucleic acid oligomers
12/21/2006US20060286571 Methods of predicting methotrexate efficacy and toxicity
12/21/2006US20060286570 contacting photoinitiator-labeled target-probe complex with polymer precursor, exposing to light; biotin, streptavidin, DNA, influenza; replace PCR and bacteria culturing
12/21/2006US20060286569 Method, apparatus, and system for authentication using labels containing nucleotide sequences
12/21/2006US20060286568 Analyzing nucleic acid sample for a deletion in nucleotide sequence; sequencing a portion of the spinocerebellar ataxia type 5 (SCA5) polynucleotide; neurodegenerative diseases; diagnosis; hybridization
12/21/2006US20060286567 Salicylamide-lanthanide complexes for use as luminescent markers
12/21/2006US20060286566 Detecting apparent mutations in nucleic acid sequences
12/21/2006US20060286565 assaying the level of RNA transcripts of gene sets in tissue samples, the expression of which is important in the diagnosis and/or prognosis of cancer, in particular of breast cancer
12/21/2006US20060286564 Modified Pol III replicases and uses thereof
12/21/2006US20060286563 Surface modified to prevent non-specific binding; magnetic field draws material to sensor to produce acoustic effect which is converted to amount of substance in sample
12/21/2006US20060286562 Methods for purifying DNA polymerases
12/21/2006US20060286561 Propargylethoxyamino nucleotides
12/21/2006US20060286560 Surface treatment
12/21/2006US20060286559 Nucleic acids for detection of Listeria
12/21/2006US20060286558 Normalization of samples for amplification reactions
12/21/2006US20060286557 Combined lysis and PCR buffer
12/21/2006US20060286556 Autoimmune encephalomyelitis; multiple sclerosis; antagonize or inhibit CXCL13
12/21/2006US20060286555 Microarray support for bioprobe synthesis
12/21/2006US20060286554 Fluid container for electrohydrodynamic spray device and method of using same
12/21/2006US20060286553 Hybridizing dimer and crosslinking probe-bearing groups; fast, doesn't require special instruments
12/21/2006US20060286552 Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence
12/21/2006US20060286551 RT-PCR detection for differential diagnosis of field isolates or lapinized vaccine strain of classical swine fever virus (CSFV) in samples
12/21/2006US20060286550 Substrates for isolating, reacting and microscopically analyzing materials
12/21/2006US20060286549 Microfluidic system for identifying or sizing individual particles passing through a channel
12/21/2006US20060286548 Method of making recombinant human antibodies for use in biosensor technology
12/21/2006US20060286547 Time-of-addition assay for identifying anti-viral compounds
12/21/2006US20060286546 Using gold-particle labelled reagents and an antibody conjugate to bind to a probe; cost efficiency, environmentally friendly
12/21/2006US20060286544 Establishment of a human embryonic stem cell line using mammalian cells
12/21/2006US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006US20060286124 Vaccine compositions and methods of treating coronavirus infection
12/21/2006US20060286119 Compositions and methods for treatment of chronic and infectious diseases
12/21/2006US20060286110 Bax-responsive genes for drug target identification in yeast and fungi
12/21/2006US20060286106 determining total protein bound or total free levels or both of one or more myeloperoxidase (MPO)-generated amino acids in a bodily sample of blood, serum, plasma, or urine from the patient
12/21/2006US20060286104 Superagonistic anti-CD28 antibodies
12/21/2006US20060286090 Mediators of epithelial adhesion and their role in cancer and skin disorders
12/21/2006US20060286080 Method for obtaining plasmid-dna by means of an aqueous biphasic system
12/21/2006US20060286036 Methods and compositions for inhibiting HIV infection
12/21/2006US20060286034 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders
12/21/2006US20060286031 Modulators of tissue regeneration
12/21/2006DE102005027796A1 Detection of an active substance for killing of murine fibrosarcoma tumor cells by releasing apoptosis effectors, comprises adding a catalase inhibitor and detecting catalase activity and apoptotis cells
12/21/2006DE102005025799A1 Verfahren zur Diagnose eines gestörten Magnesiumkanals A method of diagnosing a faulty channel magnesium
12/21/2006DE102004018171B4 Verfahren zur Akquisition von Formen aus Bildern luftgetragener Keime und/oder Pollen und zum fallbasierten Erkennen dieser Objekte in digitalen Bildern, Computer-Programm-Produkt und digitales Speichermedium zur Ausführung dieses Verfahrens A method for acquiring shapes from images of airborne germs and / or pollen and case-based recognition of objects in digital images, computer program product and digital storage medium for carrying out this method
12/21/2006DE10113042B4 HIV-Inhibitor Screening-System HIV inhibitor screening system
12/21/2006CA2640335A1 Rapid saccharide biomarker assay
12/21/2006CA2614299A1 Method of assaying blood component by using whole blood and measurement kit
12/21/2006CA2612281A1 Method for diagnosing alzheimer's disease
12/21/2006CA2612271A1 Vaccines for immunization against helicobacter
12/21/2006CA2612180A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006CA2612160A1 Enpp1 (pc-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications
12/21/2006CA2611951A1 Method of processing and/or genome mapping of ditag sequences
12/21/2006CA2611500A1 Compositions and methods for treating inflammatory conditions
12/21/2006CA2611365A1 Process for the identification of novel enzyme interacting compounds
12/21/2006CA2611361A1 Il10 snp associated with acute rejection
12/21/2006CA2611188A1 Mdr1 snp in acute rejection
12/21/2006CA2611005A1 Impdh2 snp associated with acute rejection
12/21/2006CA2610910A1 Methods and compositions for the diagnosis of venous thromboembolic disease
12/21/2006CA2610157A1 Methods of identifying and treating individuals exhibiting mutant kit protein
12/21/2006CA2606351A1 Adamts13-comprising compositions having thrombolytic activity
12/20/2006EP1734367A1 Process for the identification of novel enzyme interacting compounds
12/20/2006EP1734362A2 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices
12/20/2006EP1734134A2 A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
12/20/2006EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006EP1734132A1 Method of determining carbonic anhydrase i activity
12/20/2006EP1734126A2 Regeneration
12/20/2006EP1734125A1 Homeologous recombination in MSH2 inactivated plants or cells thereof
12/20/2006EP1734120A2 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
12/20/2006EP1734118A1 Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening
12/20/2006EP1734117A1 Novel fluorescent protein and gene encoding the same
12/20/2006EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006EP1733739A1 sFRP EXPRESSION POTENTIATING AGENT
12/20/2006EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis
12/20/2006EP1733237A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara)
12/20/2006EP1733234A2 Methods of determining allergen response using microarray imminoassay techinques
12/20/2006EP1733229A1 Patterning method for biosensor applications and devices comprising such patterns
12/20/2006EP1733206A2 Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
12/20/2006EP1733057A2 L-sign polymorphisms and methods involving use of same
12/20/2006EP1733056A2 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
12/20/2006EP1733055A2 Polynucleotide synthesis
12/20/2006EP1733054A2 Method for the quantification of methylated dna
12/20/2006EP1733053A1 Screening method for identifying pufa pks in samples
12/20/2006EP1733052A1 Pdk4 as marker for ppardelta modulation
12/20/2006EP1733051A2 Method and biomarkers for detecting tumor endothelial cell proliferation
12/20/2006EP1733050A2 Method for recognizing signatures in complex gene expression profiles
12/20/2006EP1733049A1 Method of diagnosis of a predisposition to develop thrombotic disease and its uses
12/20/2006EP1733048A1 Neisseria gonorrhoeae detection
12/20/2006EP1733047A2 Pin-prc transition genes
12/20/2006EP1733046A1 Combination therapies with epothilones and carboplatin
12/20/2006EP1733045A1 Design and therapeutic use of adpase enhanced apyrases
12/20/2006EP1733044A2 Method and device for testing the bactericidal effect of substances
12/20/2006EP1733043A1 Method and apparatus for implementing threshold based correction functions for biosensors
12/20/2006EP1733036A2 Cancer prognosis and/or diagnosis method
12/20/2006EP1733030A2 Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxygenase and methods of using the same
12/20/2006EP1733023A2 Thermal cycling device
12/20/2006EP1732989A1 Fluorescent labeled nucleotide derivatives
12/20/2006EP1732963A2 High molecular weight polymer based on n,n-dimethylacrylamide